AU2002357468A1 - Use of 2-acylindoles in the treatment of tumors - Google Patents

Use of 2-acylindoles in the treatment of tumors

Info

Publication number
AU2002357468A1
AU2002357468A1 AU2002357468A AU2002357468A AU2002357468A1 AU 2002357468 A1 AU2002357468 A1 AU 2002357468A1 AU 2002357468 A AU2002357468 A AU 2002357468A AU 2002357468 A AU2002357468 A AU 2002357468A AU 2002357468 A1 AU2002357468 A1 AU 2002357468A1
Authority
AU
Australia
Prior art keywords
acylindoles
tumors
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002357468A
Inventor
Thomas Beckers
Markus Frieser
Jorg Hockemeyer
Harald Hufsky
Siavosh Mahboobi
Herwig Pongratz
Udo Vanhoefer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Baxter International Inc
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of AU2002357468A1 publication Critical patent/AU2002357468A1/en
Abandoned legal-status Critical Current

Links

AU2002357468A 2001-10-26 2002-10-24 Use of 2-acylindoles in the treatment of tumors Abandoned AU2002357468A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10152306.8 2001-10-26

Publications (1)

Publication Number Publication Date
AU2002357468A1 true AU2002357468A1 (en) 2003-05-12

Family

ID=

Similar Documents

Publication Publication Date Title
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
AU2002339157A1 (en) Inhibitors of the notch signalling pathway for use in the treatment of cancer
AU2003213144A1 (en) Alkylating agent combinations in the treatment of cancer
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
EP1465997A4 (en) Use of biomolecular targets in the treatment and visualization of tumors
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2001260834A1 (en) The treatment of herpes
AU2002319286A1 (en) Skin treatment
AU2002243363A1 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
AU2002335667A1 (en) Modified reoviral therapy
IL160722A0 (en) Aryloxypropylamines as chemosensitizing agents in the treatment of cancer
AU2002304883A1 (en) Device for the treatment of tumours
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2001257325A1 (en) Cancer treatment
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
AU2002328383A1 (en) Equipment for treating painful points in the organism
AU2002305138A1 (en) Methods and materials for cancer treatment
AU2002357468A1 (en) Use of 2-acylindoles in the treatment of tumors
AU2001289127A1 (en) Tumor treatment
AU2002350513A1 (en) Use of solasonine for the treatment of skin tumors
AU2002254524A1 (en) Use of semenogelin in the diagnosis, prognosis and treatment of cancer
AU2002351382A1 (en) Combination cancer therapy
AU2003247094A1 (en) Enhancing the effect of radioimmunotherapy in the treatment of tumors
AU2001257168A1 (en) Cancer treatment